Business Context and Reporting Period
Company: Atricure, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 30, 2013
Event: Entry into a Material Definitive Agreement regarding credit facility modifications.
Key Financial Metrics
This filing does not report specific revenue, profit, cash flow, or margin figures. The document focuses on the restructuring of debt covenants rather than operational performance metrics for a specific period.
Material Changes
Effective January 30, 2013, Atricure, Inc. entered into modification agreements with Silicon Valley Bank and the Export-Import Bank. Key changes include:
- New Borrower: The Company's wholly-owned subsidiary, AtriCure, LLC, was added as a borrower to the credit facility.
- Covenant Adjustment: The minimum EBITDA amount required to meet the EBITDA covenant was decreased.
- Forecast Timing: The timing for submitting financial forecasts to the Bank was modified.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on future outlook, or specific risk factors beyond the terms of the loan modification. The primary contingency noted is the Company's obligation to adhere to the revised EBITDA covenants and forecast submission schedules outlined in the attached agreements.
Investor Verification Checklist
- Review the full text of the "Joinder and Fifth Loan Modification Agreement" (Exhibit 10.1) for specific EBITDA thresholds.
- Review the "Export-Import Bank Joinder and Third Loan Modification Agreement" (Exhibit 10.2) for additional terms.
- Verify the impact of adding AtriCure, LLC as a borrower on the Company's consolidated debt obligations.
- Confirm the new schedule for forecast submissions to ensure compliance with the Bank.